30 Participants Needed

Hyperpolarized Gas MRI for Bronchopulmonary Dysplasia

DM
Overseen ByDavid M Biko, MD
Age: < 18
Sex: Any
Trial Phase: Phase 1
Sponsor: Xemed LLC
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What data supports the effectiveness of the treatment MagniXene, hyperpolarized 129Xe MRI, for bronchopulmonary dysplasia?

The research suggests that hyperpolarized 129Xe MRI is a promising technique for evaluating lung function in children without using harmful radiation. It has been used to understand lung diseases like asthma and cystic fibrosis, indicating its potential usefulness in assessing and managing bronchopulmonary dysplasia.12345

Is hyperpolarized 129Xe MRI safe for use in humans?

Research indicates that hyperpolarized 129Xe MRI has been studied for safety and tolerability in children, including those with cystic fibrosis, suggesting it is generally safe for human use.12356

How is hyperpolarized gas MRI different from other treatments for bronchopulmonary dysplasia?

Hyperpolarized gas MRI is unique because it uses special gases like helium-3 and xenon-129 to create detailed images of the lungs without using harmful radiation. This allows doctors to see how well the lungs are working and to track changes over time, which is especially useful for children with lung conditions like bronchopulmonary dysplasia.12378

What is the purpose of this trial?

Hyperpolarized (HP) gas magnetic resonance imaging (MRI) of the lungs offers additional information that cannot be obtained with CT scan, the current gold standard for imaging this disorder. As a nonionizing technique, MRI is an ideal modality for pulmonary imaging; in particular in the infant and pediatric population. Nevertheless, due to the low proton density of the lung parenchyma (only \~20% that of solid tissues), numerous air-tissue interfaces that lead to rapid signal decay, and cardiac and respiratory sources of motion that further degrade image quality , MRI has played a limited role in the evaluation of lung pathologies. In this setting, HP gas (using 129Xe) MRI may play a role in helping determine the regional distribution of alveolar sizes, partial pressure of oxygen, alveolar wall thickness, and gas transport efficiency of the microvasculature within the lungs of infants with a diagnosis of bronchopulmonary dysplasia (BPD).

Research Team

DM

David M Biko, MD

Principal Investigator

Children's Hospital of Philadelphia

Eligibility Criteria

This trial is for infants in the NICU at Children's Hospital of Philadelphia with bronchopulmonary dysplasia (BPD), who are on mechanical ventilation and already receiving sedation. Infants considered unstable for transport to MRI by their primary care team cannot participate.

Inclusion Criteria

I am on a mechanical ventilator through a tube or tracheostomy.
Babies with lung problems who are being cared for at the Children's Hospital of Philadelphia and are part of the Chronic Lung Disease Program.
I am currently receiving sedation as part of my treatment.

Exclusion Criteria

Infants whom the primary care team deems to be unstable for transport to MRI

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Imaging

Participants undergo hyperpolarized 129-Xenon MR imaging and conventional proton MR imaging of the lung

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after imaging

2 years

Treatment Details

Interventions

  • MagniXene, hyperpolarized 129Xe MRI
Trial Overview The study tests a new type of lung imaging called hyperpolarized 129Xe MRI, using MagniXene gas. This technique could provide more detailed images of the lungs than current methods, which is especially important for diagnosing and understanding BPD in infants.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Hyperpolarized 129Xe MRI for lung diagnosisExperimental Treatment1 Intervention
All subjects will undergo hyperpolarized 129-Xenon MR imaging (HP MRI) and conventional proton MR imaging of lung.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Xemed LLC

Lead Sponsor

Trials
8
Recruited
370+

Children's Hospital of Philadelphia

Collaborator

Trials
749
Recruited
11,400,000+

Findings from Research

Magnetic resonance imaging (MRI) using hyperpolarised gases like helium-3 and xenon-129 allows for detailed structural and functional assessments of the lungs without the risks associated with ionising radiation, making it particularly suitable for pediatric patients.
This imaging technique is crucial for understanding and treating chronic lung diseases such as asthma and cystic fibrosis, which are common in children and currently have significant unmet therapeutic needs.
Pulmonary functional magnetic resonance imaging for paediatric lung disease.Kirby, M., Coxson, HO., Parraga, G.[2013]
A new continuous-flow system for producing hyperpolarized xenon (129Xe) has been developed, achieving production rates of 0.3 liters per hour with 64% polarization, significantly improving the availability of this imaging agent for lung MRI studies.
This technology allows for the production of multiliter quantities of hyperpolarized xenon several times daily, enabling more extensive human lung imaging studies that were previously limited by the availability of hyperpolarized gas.
Large production system for hyperpolarized 129Xe for human lung imaging studies.Hersman, FW., Ruset, IC., Ketel, S., et al.[2022]
Hyperpolarized gas MRI is a promising non-invasive imaging technique that can effectively diagnose early lung function deterioration, overcoming challenges faced by traditional proton-based MRI due to short T2* times and low proton density in lung tissue.
This review highlights various applications of hyperpolarized gas MRI, including ventilation imaging and oxygen-pressure mapping, which enhance its diagnostic capabilities compared to other MRI methods and could significantly improve lung disease management.
Hyperpolarized gas MRI in pulmonology.Kern, AL., Vogel-Claussen, J.[2020]

References

Pulmonary functional magnetic resonance imaging for paediatric lung disease. [2013]
Large production system for hyperpolarized 129Xe for human lung imaging studies. [2022]
Hyperpolarized gas MRI in pulmonology. [2020]
Hyperpolarized Gas Magnetic Resonance Lung Imaging in Children and Young Adults. [2020]
Initial feasibility and challenges of hyperpolarized 129 Xe MRI in neonates with bronchopulmonary dysplasia. [2023]
Feasibility, tolerability and safety of pediatric hyperpolarized 129Xe magnetic resonance imaging in healthy volunteers and children with cystic fibrosis. [2022]
Applications of hyperpolarized helium-3 gas magnetic resonance imaging in pediatric lung disease. [2019]
The role of hyperpolarized 129xenon in MR imaging of pulmonary function. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security